Clinical Trial Update: Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized pilot study evaluating pre-treatment with ranibizumab before diabetic vitrectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Retinal Neovascularisation

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Moorfields Eye Hospital NHS Foundation Trust | Conditions: Diabetic Retinopathy, Retinal Neovascularisation | Phase 4 | Status: COMPLETED